SOUTH SAN FRANCISCO, Calif.--AxyS Pharmaceuticals here last month received US patents on two proprietary genes, TULP 1 and TULP 2, that have been linked to two disease states. The disease linkages and details of some of the properties of TULP 1 are being published in the current issue of Nature Genetics, according to John Walker, AxyS's chairman and CEO. He declined further comment on the patents pending publication of the article.
AxyS Pharmaceuticals Gains US Patents on Two Genes Linked to Disease
Dec 21, 1998